Novel transdermal formulation platform designed to produce innovative and effective products for pain, inflammation, and muscle relaxant delivered directly at the site of injury avoiding side effects associated with oral delivery

 

Novel biosensor device uses impedance spectroscopy that generates a specific signal amplitude range for each cytokine without being susceptible to cross reactivity. This device can simultaneously identify several cytokines with no sample preparation or training required. This device does not require a laboratory setting or the addition of any reagents giving results in minutes with high sensitivity.